Glioma: all 1,425 studies
Page 5 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Adoptive Cellular Therapy in Pediatric Patients With High-grade GliomasTerminatedNCT03334305Phase 1Results posted
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPGTerminatedNCT03330197Phase 1/2Results posted
- Study of AMG 596 in Patients With EGFRvIII Positive GlioblastomaTerminatedNCT03296696Phase 1Results posted
- ONC201 in Adults With Recurrent H3 K27M-mutant GliomaTerminatedNCT03295396Phase 2Results posted
- Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant GliomaCompletedNCT03278249Not applicableResults posted
- The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade GliomaCompletedNCT03242824Phase 2Results posted
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)CompletedNCT03233204Phase 2Results posted
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)CompletedNCT03220035Phase 2Results posted
- Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)Active, not recruitingNCT03213704Phase 2Results posted
- Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)CompletedNCT03213678Phase 2Results posted
- Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)CompletedNCT03213665Phase 2Results posted
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Active, not recruitingNCT03213652Phase 2Results posted
- Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 MutationsActive, not recruitingNCT03212274Phase 2Results posted
- Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)Active, not recruitingNCT03210714Phase 2Results posted
- Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in GliomaTerminatedNCT03168919Not applicableResults posted
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Active, not recruitingNCT03155620Phase 2Results posted
- HUMC 1612: Optune NovoTTF-200A SystemCompletedNCT03128047Phase 1Results posted
- Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant GliomaCompletedNCT03072134Phase 1Results posted
- Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in ChildrenCompletedNCT03043391Phase 1Results posted
- Protein Phosphatase 2A Inhibitor, in Recurrent GlioblastomaCompletedNCT03027388Phase 2Results posted
- Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)TerminatedNCT03018288Phase 2Results posted
- Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and TemozolomideCompletedNCT02991456Phase 2Results posted
- Lerapolturev in Recurrent Malignant GliomaCompletedNCT02986178Phase 2Results posted
- Long Term Survivors of High-grade Glioma and Their CaregiversCompletedNCT02965144Results posted
- H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other GliomasCompletedNCT02960230Phase 1/2Results posted
- Multi-Parametric Quantitative MR Imaging in Evaluation of Brain TumorsCompletedNCT02956291Not applicableResults posted
- A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)TerminatedNCT02924038Phase 1Results posted
- A Microdose Evaluation Study of ABY-029 in Recurrent GliomaCompletedNCT02901925Early Phase 1Results posted
- Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive GlioblastomaCompletedNCT02858895Phase 2Results posted
- Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing SurgeryTerminatedNCT02855086Phase 1/2Results posted
- Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade GliomasCompletedNCT02849171Not applicableResults posted
- Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant GliomaCompletedNCT02794883Phase 2Results posted
- Temozolomide Chronotherapy for High Grade GliomaCompletedNCT02781792Phase 2Results posted
- Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsCompletedNCT02780804Phase 1Results posted
- First in Patient Study for PF-06840003 in Malignant GliomasTerminatedNCT02764151Phase 1Results posted
- Trial of Panobinostat in Children With Diffuse Intrinsic Pontine GliomaCompletedNCT02717455Phase 1Results posted
- Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsCompletedNCT02684058Phase 2Results posted
- TTFields and Pulsed Bevacizumab for Recurrent GlioblastomaTerminatedNCT02663271Phase 2Results posted
- Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With GlioblastomaCompletedNCT02661282Phase 1/2Results posted
- Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001CompletedNCT02655601Phase 1/2Results posted
- A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation TherapyTerminatedNCT02607124Phase 1/2Results posted
- Phase 2 Study of Sym004 for Adult Patients With Recurrent GlioblastomaCompletedNCT02540161Phase 2Results posted
- Nivolumab With DC Vaccines for Recurrent Brain TumorsCompletedNCT02529072Phase 1Results posted
- Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersCompletedNCT02526017Phase 1Results posted
- Oral ONC201 in Adult Recurrent GlioblastomaTerminatedNCT02525692Phase 2Results posted
- Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade GliomaCompletedNCT02490800Phase 1/2Results posted
- Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma MultiformeCompletedNCT02465268Phase 2Results posted
- Sedatives' Effects on Neurological Function in Patients With Eloquent Area GliomaCompletedNCT02439164Not applicableResults posted
- Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain TumorsTerminatedNCT02372409Phase 2Results posted
- Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway GliomasCompletedNCT02343224Phase 2Results posted
- Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETsTerminatedNCT02332889Phase 1/2Results posted
- Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and BevacizumabCompletedNCT02330562Phase 1/2Results posted
- Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasCompletedNCT02323880Phase 1Results posted
- Early-Phase Safety of Proton Therapy EquipmentCompletedNCT02315989Not applicableResults posted
- Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade GliomasCompletedNCT02313272Phase 1Results posted
- MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant GliomasCompletedNCT02311582Phase 1/2Results posted
- Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCompletedNCT02273739Phase 1/2Results posted
- Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant GliomaActive, not recruitingNCT02208362Phase 1Results posted
- Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasActive, not recruitingNCT02192359Phase 1Results posted
- Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade GliomasCompletedNCT02186509Phase 1Results posted
- 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent GliomasTerminatedNCT02175745Not applicableResults posted
- Molecular-Guided Therapy for Childhood CancerCompletedNCT02162732Not applicableResults posted
- Hypofractionated IMRT With Temozolomide for HGGCompletedNCT02082119Not applicableResults posted
- Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeCompletedNCT02078648Phase 1/2Results posted
- Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant GliomaActive, not recruitingNCT02062827Phase 1Results posted
- Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade GliomaTerminatedNCT02039778Not applicableResults posted
- A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant GliomaCompletedNCT02026271Phase 1Results posted
- Everolimus With and Without Temozolomide in Adult Low Grade GliomaTerminatedNCT02023905Phase 2Results posted
- 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation TherapyCompletedNCT01991977Phase 2Results posted
- Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent GliomasTerminatedNCT01986348Phase 2Results posted
- Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade GliomaCompletedNCT01977677Phase 1/2Results posted
- Photodynamic Therapy (PDT) For Recurrent High Grade GliomasTerminatedNCT01966809Phase 2Results posted
- Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine GliomasCompletedNCT01922076Phase 1Results posted
- Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22TerminatedNCT01884740Phase 1/2Results posted
- Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade GliomaCompletedNCT01817751Phase 2Results posted
- Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine GliomaTerminatedNCT01774253Phase 2Results posted
- A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With BevacizumabTerminatedNCT01743950Phase 2Results posted
- Bevacizumab Beyond Progression (BBP)CompletedNCT01740258Phase 2Results posted
- Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma PatientsCompletedNCT01738646Phase 2Results posted
- Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT01648348Phase 1/2Results posted
- Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT01635283Phase 2Results posted
- Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent GliomaCompletedNCT01580969Phase 1/2Results posted
- Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway GliomaCompletedNCT01553149Phase 2Results posted
- Imaging Study of Glioblastomas Treated With AvastinTerminatedNCT01549392Not applicableResults posted
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine GliomasCompletedNCT01514201Phase 1/2Results posted
- Vinorelbine for Children With Progressive or Recurrent Low-grade GliomasCompletedNCT01497860Phase 2Results posted
- PVSRIPO for Recurrent Glioblastoma (GBM)CompletedNCT01491893Phase 1Results posted
- Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaCompletedNCT01462695Phase 2Results posted
- CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIIICompletedNCT01454596Phase 1/2Results posted
- Ovarian Aging in Low Grade Glioma (LGG) Treated With TemozolomideTerminatedNCT01452854Results posted
- Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving TemozolomideCompletedNCT01450826Phase 2Results posted
- Phase I-II Everolimus and Sorafenib in Recurrent High-Grade GliomasCompletedNCT01434602Phase 1/2Results posted
- Lacosamide in Preventing Seizures in Participants With Malignant GliomaTerminatedNCT01432171Not applicableResults posted
- Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following BevacizumabCompletedNCT01403610Phase 2Results posted
- Nuvigil or Placebo in Newly Diagnosed Malignant GliomaTerminatedNCT01400958Phase 2Results posted
- Comparative Study of Intraoperative MRI-guided vs. Conventional Glioma SurgeryCompletedNCT01394692Not applicableResults posted
- A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade GliomaCompletedNCT01390948Phase 2Results posted
- Functional Monitoring for Motor Pathway in Brain Tumor Surgery Within Eloquent AreaCompletedNCT01351337Not applicableResults posted
- Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade AstrocytomasTerminatedNCT01338857Phase 2Results posted
- Low Dose Naltrexone for Glioma PatientsCompletedNCT01303835Phase 2Results posted